Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1652 1654 1658
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18450487 | COMBINATION THERAPY COMPRISING LONG ACTING GLP-1/GLUCAGON AND NPY2 RECEPTOR AGONISTS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18389544 | METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Non-Final OA | Jiu-Yao Wang |
| 18490806 | TOPICAL COMPOSITION FOR REGULATION OF INFLAMMATION AND SKIN REGENERATION | Non-Final OA | Glycopep Therapeutics, S.A.S. de C.V. |
| 18462852 | SMALL-MOLECULE PEPTIDE AND USE THEREOF AGAINST METABOLIC-ASSOCIATED FATTY LIVER DISEASE AND FOR REDUCING BODY WEIGHT | Non-Final OA | Tunghai University |
| 18043230 | INTERLEUKIN-1 RECEPTOR MODULATORS AND USES THEREOF | Non-Final OA | VALORISATION-RECHERCHE, LIMITED PARTNERSHIP |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy